Treatment
Insulin aspart clinical trials
We’re tracking 6 recruiting studies that include Insulin aspart, each written for real people, not researchers, below.
Recruiting studies
- NCT07076199RecruitingPhase 3
Weekly vs daily insulin for type 1 diabetes
This study tests a new once-weekly insulin (icodec) against a standard daily insulin (glargine), both taken with mealtime insulin. It aims to see which works better to control blood sugar in adults with type 1 diabetes.
Cullman, AlabamaAges 18 years+ - NCT06547619RecruitingEarly Phase 1
Blood vessel health after pregnancy with diabetes
This study looks at how blood vessels work in women who had a healthy pregnancy or gestational diabetes. It tests if a substance called ET-1 affects blood vessel function.
Iowa City, IowaAges 18–50 - NCT03987308Recruiting
Test shot medicine versus insulin pump for new type 2 diabetes
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
Beijing, Beijing MunicipalityAges 18–70 - NCT05221359Recruiting
Safety trial of ExOlin® for adults with hard-to-control type 1 diabetes
This trial checks whether ExOlin® is safe in adults with type 1 diabetes who have had difficult blood sugar control or injection-site skin problems despite insulin pump and continuous glucose monitoring. It’s mainly looking for safety and comfort while using the treatment devices.
StrasbourgAges 18 years+ - NCT05946785RecruitingEarly Phase 1
Study of blood-vessel changes after gestational diabetes
This early-stage study looks at how “oxidative stress” (cell damage from stress molecules) may affect small blood vessels after pregnancy, especially in people who had gestational diabetes. The goal is to better understand what’s going on and whether these changes could be linked to future health risks.
Iowa City, IowaAges 18–50 - NCT06558708RecruitingPhase 2
Comparing two once-daily insulins for type 2 diabetes
This trial compares two once-daily insulin injections to see which works better and is safer for people with type 2 diabetes. Both are new types of insulin designed to help control blood sugar with fewer side effects.
TianjinAges 18–75
What Insulin aspart is being studied for
Conditions with recruiting Insulin aspart studies.
Common questions
- Are there clinical trials studying Insulin aspart?
- Yes. Clin2 currently lists 6 recruiting studies that include Insulin aspart, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Insulin aspart trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Insulin aspart an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Insulin aspart or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.